BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,273,800 | -16.6% | 33,752 | 0.0% | 0.43% | -8.5% |
| Q2 2023 | $1,526,603 | -5.1% | 33,752 | 0.0% | 0.47% | -10.2% |
| Q1 2023 | $1,609,295 | -7.9% | 33,752 | -1.6% | 0.53% | -11.6% |
| Q4 2022 | $1,748,118 | -10.2% | 34,297 | -5.1% | 0.60% | -20.3% |
| Q3 2022 | $1,946,000 | -16.2% | 36,134 | 0.0% | 0.75% | -18.3% |
| Q2 2022 | $2,321,000 | -17.2% | 36,134 | 0.0% | 0.92% | -11.5% |
| Q1 2022 | $2,802,000 | -9.9% | 36,134 | -0.3% | 1.03% | -8.6% |
| Q4 2021 | $3,110,000 | +6.7% | 36,234 | 0.0% | 1.13% | -5.3% |
| Q3 2021 | $2,914,000 | -0.1% | 36,234 | 0.0% | 1.19% | +0.1% |
| Q2 2021 | $2,917,000 | -4.5% | 36,234 | 0.0% | 1.19% | -12.5% |
| Q1 2021 | $3,056,000 | +5.3% | 36,234 | +0.1% | 1.36% | -2.3% |
| Q4 2020 | $2,903,000 | +0.0% | 36,184 | +0.3% | 1.40% | -11.8% |
| Q3 2020 | $2,902,000 | -6.6% | 36,084 | 0.0% | 1.58% | -12.3% |
| Q2 2020 | $3,107,000 | +6.0% | 36,084 | 0.0% | 1.80% | -13.3% |
| Q1 2020 | $2,930,000 | -2.9% | 36,084 | 0.0% | 2.08% | +25.1% |
| Q4 2019 | $3,017,000 | -4.4% | 36,084 | 0.0% | 1.66% | -10.8% |
| Q3 2019 | $3,156,000 | +6.7% | 36,084 | -0.0% | 1.86% | +3.6% |
| Q2 2019 | $2,957,000 | +0.7% | 36,100 | 0.0% | 1.80% | -1.7% |
| Q1 2019 | $2,935,000 | +23.5% | 36,100 | 0.0% | 1.83% | +9.5% |
| Q4 2018 | $2,376,000 | -14.6% | 36,100 | 0.0% | 1.67% | +2.4% |
| Q3 2018 | $2,783,000 | +4.4% | 36,100 | 0.0% | 1.63% | -3.5% |
| Q2 2018 | $2,666,000 | +29.7% | 36,100 | +14.2% | 1.69% | +26.5% |
| Q1 2018 | $2,055,000 | +0.6% | 31,600 | 0.0% | 1.34% | +4.2% |
| Q4 2017 | $2,043,000 | +3.0% | 31,600 | 0.0% | 1.28% | -2.1% |
| Q3 2017 | $1,983,000 | +3.7% | 31,600 | 0.0% | 1.31% | -0.2% |
| Q2 2017 | $1,913,000 | +16.7% | 31,600 | 0.0% | 1.31% | +14.3% |
| Q1 2017 | $1,639,000 | +17.0% | 31,600 | 0.0% | 1.15% | -1.1% |
| Q4 2016 | $1,401,000 | -6.2% | 31,600 | 0.0% | 1.16% | -10.5% |
| Q3 2016 | $1,494,000 | +549.6% | 31,600 | +532.0% | 1.30% | -44.4% |
| Q2 2016 | $230,000 | -82.5% | 5,000 | -84.2% | 2.34% | +92.6% |
| Q1 2016 | $1,317,000 | +12.1% | 31,600 | 0.0% | 1.21% | +7.6% |
| Q4 2015 | $1,175,000 | +18.8% | 31,600 | +5.0% | 1.13% | +10.9% |
| Q3 2015 | $989,000 | -56.2% | 30,100 | -6.8% | 1.02% | -46.0% |
| Q2 2015 | $2,258,000 | +1.8% | 32,300 | -0.3% | 1.88% | -1.4% |
| Q1 2015 | $2,219,000 | -6.8% | 32,400 | -0.3% | 1.91% | -5.3% |
| Q4 2014 | $2,381,000 | – | 32,500 | – | 2.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |